| Variable |
N (%) |
Age at onset
Years Range (Mean) |
2-12 (7.5) |
Sex
Male
Female |
12 (57.1)
9 (42.9) |
Seasonal clustering
Winter-spring
Summer
Late fall |
17 (80.9)
1 (4.8)
3 (14.3) |
pH of preceding infections
None
URTI
Age
Vaccination |
6 (28.6)
12 (57.1)
2 (9.5)
1 (4.8) |
Systemic signs and symptoms
Fever
Nausea and vomiting
Headache
Neck stiffness |
9 (42.9)
4 (19.04)
6 (23.8)
2 (9.5) |
Neurological symptoms and signs
Neurological deficit
Ataxia
Hemiparesis
Paraparesis
Monoparesis
Convulsion
Focal
Generalized
Eye signs/symptoms
Eye ache and visual disturbances
Oculomotor nerve palsy
Impairment of consciousness
Urinary symptoms
Sensory deficits |
9 (42.9)
4 (19)
2 (9.5)
1 (4.8)
2 (9.5)
6 (23.8)
2 (9.5)
4 (19.04)
3 (14.3)
1 (4.8)
2 (9.5)
3 (14.3)
1 (4.8)
2 (9.5) |
| Duration of stay in hospital |
7-31 days (14.3 days) |
Treatment
Steroid alone
Oral prednisone
Intravenous methylprednisolone
Steroid with IVGG |
15 (71.4)
12 (57.1)
3 (14.3)
6 (28.6) |
Outcome
No neurological residual deficits
Neurological residual deficits
Gait disturbances
Paraparesis
Hemiparesis |
16 (76.2)
5 (23.8)
3 (14.3)
1 (4.7)
1 (4.7) |